The Health Sciences Authority (HSA) Singapore has published an update regarding the notification of lot release information of imported registered vaccines before they are supplied to Singapore, and this information was updated on their official website in March 2022.
Product registrants are required to adhere to this from 1 July 2022 for vaccines placed under routine lot release programme (Group 1) and for vaccines placed under alternate to lot release programme (Group 2).
The notification can be submitted by filling up the “Notification of Vaccine Lot Release Information Form” before the vaccines are supplied to Singapore. The final form will be available from 1 July 2022.
More details can be found in “Notification of lot release information of imported vaccines for local supply, March 2022”: https://www.hsa.gov.sg/therapeutic-products/register/vaccine-lot-release